Treatment options for ovarian cancer
/Up to 85 percent of women experience recurrence of high-grade serous ovarian cancer — the most common subtype of ovarian cancer — after standard treatment with the chemotherapy drug carboplatin.
Read MoreUp to 85 percent of women experience recurrence of high-grade serous ovarian cancer — the most common subtype of ovarian cancer — after standard treatment with the chemotherapy drug carboplatin.
Read MoreDeaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA & European Union.
Read MoreMany women understand the risk factors or breast cancer but few understand its link with ovarian cancer. Every woman needs to read this.
Read More